Physician profile
Neil A Ettinger
NPI 1619086451
$70,877.71
in general payments reported to CMS, 2019-2025
65 companies · $9,705 in 2025
The $9,705 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $13K · 2021: $10K · 2022: $5,619 · 2023: $9,847 · 2024: $5,226 · 2025: $9,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $8,501 · Education: $37.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,240.00 |
| Food and Beverage | $8,500.89 |
| Education | $37.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $57,763.68 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Glaxosmithkline, LLC. | $2,195.11 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,850.82 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Insmed, INC. | $864.58 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $754.60 | 2019-2025 | Dupixent |
| Genzyme Corporation | $638.82 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $528.48 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $500.82 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| United Therapeutics Corporation | $499.35 | 2019-2025 | Tyvaso, Orenitram, Tyvaso |
| Novartis Pharmaceuticals Corporation | $398.79 | 2019-2025 | |
| Amgen INC. | $388.81 | 2020-2025 | Tezspire, Tavneos |
| Mylan Specialty L.P. | $374.04 | 2019-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $360.80 | 2019-2025 | Zerbaxa, Verquvo, Winrevair |
| Grifols USA, LLC | $355.49 | 2019-2025 | Prolastin-C Liquid |
| Electromed, INC. | $336.54 | 2019-2025 | Smartvest |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $308.52 | 2019-2024 | Xolair |
| Philips North America LLC | $308.17 | 2019-2025 | (8874) Incourage, Vest Therapy Und, Encore |
| Pfizer INC. | $268.85 | 2019-2025 | |
| Baxter Healthcare | $212.82 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| E.R. Squibb & Sons, L.L.C. | $202.66 | 2019-2024 | Eliquis |
| Amarin Pharma, INC. | $181.52 | 2020-2022 | |
| Tactile Systems Technology INC | $175.84 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Intuitive Surgical, INC. | $155.27 | 2023-2024 | |
| Medtronic, INC. | $141.05 | 2023 | Illumisite |
| Ani Pharmaceuticals, INC. | $140.92 | 2024-2025 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $109.97 | 2019-2023 | Veklury |
| Viatris Specialty LLC | $101.66 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $95.36 | 2019 | |
| Boston Scientific Corporation | $87.63 | 2019-2022 | |
| Verona Pharma, INC. | $65.87 | 2025 | Ohtuvayre |
| Resmed Corp | $49.38 | 2019-2024 | |
| Advanced Respiratory, INC | $49.15 | 2019-2020 | |
| Phadia US INC. | $46.39 | 2023 | Immunocap |
| Teva Pharmaceuticals USA, INC. | $42.07 | 2019-2023 | |
| Harmony Biosciences LLC | $33.89 | 2024 | |
| Axsome Therapeutics, INC. | $32.88 | 2025 | Sunosi |
| Nabriva Therapeutics, Plc | $29.86 | 2020 | |
| Janssen Biotech, INC. | $22.97 | 2024 | Tremfya |
| Paratek Pharmaceuticals, INC. | $20.78 | 2025 | Nuzyra |
| Vifor Pharma, INC. | $16.53 | 2025 | Zemaira |
| Sanofi Pasteur INC. | $16.45 | 2019 | |
| Azurity Pharmaceuticals, INC. | $16.00 | 2025 | Alvesco |
| Sanofi-Aventis U.S. LLC | $15.72 | 2021 | |
| Medtronic Vascular, INC. | $15.23 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.95 | 2020 | |
| Erbe USA INC | $13.00 | 2023 | Erbe |
| Kowa Pharmaceuticals America, INC. | $12.62 | 2021 | |
| Inari Medical, INC. | $12.37 | 2021 | |
| Covis Pharma Gmbh | $12.27 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.92 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $11.54 | 2019 | |
| Fisher & Paykel Healthcare INC | $10.31 | 2019 | |
| Itamar Medical INC | $5.59 | 2024 | Watchpatone |
12 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$140.92 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Ettinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.